Hybrid Remote and In-Clinic Maternal–Fetal Surveillance in Gestational Diabetes

The following summary provides a high-level overview of a peer-reviewed article published in 2025 in the International Journal of Gynecology & Obstetrics, outlining the study’s methodology, key findings, and clinical implications related to hybrid maternal–fetal surveillance.

The full article is available at:
https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.16148

Study Objective:

This prospective pilot study evaluated the feasibility, safety, and effectiveness of a hybrid maternal–fetal surveillance model for women with gestational diabetes mellitus (GDM) in late pregnancy.

Study Design:

The hybrid care model combined:

• Remote follow-up visits, including telemedicine-based monitoring and counseling.
  
  
• In-clinic visits for standard maternal-fetal assessment.
  
  

Participants were followed for four weeks, with one remote visit and one in-clinic visit per week.

The study assessed:

1. Feasibility and completion rates of remote visits
   
   
2. Patient time burden
   
   
3. Patient satisfaction
   
   
4. Adherence to glucose monitoring
   
   
5. Maternal and neonatal clinical outcomes

Key Findings:

1. High feasibility:
   Remote visits were successfully completed in 97.4% of cases.
   
   
2. Reduced patient time burden:
   Remote visits were significantly shorter than in-clinic visits (approximately 30 minutes vs. 2.5 hours).
   
   
3. High patient satisfaction:
   Participants reported very high satisfaction scores (mean 6.6 out of 7).
   
   
4. Improved adherence:
   Compliance with glucose monitoring and documentation was higher during the hybrid care period compared with post-study follow-up.
   
   
5. No adverse clinical impact:
   No increase in adverse maternal or neonatal outcomes was observed, including no cases of macrosomia or severe neonatal hypoglycemia.
   
   

Overall, the hybrid model maintained clinical safety while improving efficiency and patient experience.

The Importance of NUVO in Hybrid Maternal-Fetal Monitoring:

Although INVU were not directly evaluated, the study findings support key principles underlying digital maternal-fetal monitoring platforms:

1. Validation of hybrid care models:
   The study provides clinical evidence that combining remote and in-clinic surveillance is feasible and safe.
   
   
2. Operational efficiency:
   Reduced visit duration aligns with the ability of digital platforms to optimize clinic workflows while maintaining clinical oversight.
   
   
3. Improved patient engagement and adherence:
   Higher compliance and satisfaction underscore the benefits of continuous, technology-enabled monitoring outside the clinic.
   
   
4. No compromise in clinical outcomes:
   The absence of negative maternal or neonatal outcomes supports the integration of advanced remote monitoring solutions into standard care pathways.

This study supports the clinical rationale for hybrid maternal–fetal surveillance models, demonstrating that remote monitoring can safely complement in-clinic care for women with gestational diabetes. The findings align with the intended use of digital monitoring platforms such as  INVU, particularly with respect to efficiency, patient experience, adherence, and continuity of care.